511 related articles for article (PubMed ID: 11597556)
1. p63 protein expression is rare in prostate adenocarcinoma: implications for cancer diagnosis and carcinogenesis.
Parsons JK; Gage WR; Nelson WG; De Marzo AM
Urology; 2001 Oct; 58(4):619-24. PubMed ID: 11597556
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancer.
Shah RB; Zhou M; LeBlanc M; Snyder M; Rubin MA
Am J Surg Pathol; 2002 Sep; 26(9):1161-8. PubMed ID: 12218572
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells.
Weinstein MH; Signoretti S; Loda M
Mod Pathol; 2002 Dec; 15(12):1302-8. PubMed ID: 12481011
[TBL] [Abstract][Full Text] [Related]
4. [Assessment of P504S immunohistochemistry in diagnosis and differential diagnosis of prostatic adenocarcinoma].
Chen GY; Liu LN; Zhou XG; Zhang CH; Huang SF
Zhonghua Bing Li Xue Za Zhi; 2004 Oct; 33(5):419-23. PubMed ID: 15498210
[TBL] [Abstract][Full Text] [Related]
5. Comparison of 34betaE12 and P63 in 100 consecutive prostate carcinoma diagnosed by needle biopsies.
Wu HH; Lapkus O; Corbin M
Appl Immunohistochem Mol Morphol; 2004 Dec; 12(4):285-9. PubMed ID: 15536326
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of basal cell cocktail (34betaE12 + p63) in the diagnosis of atypical prostate glandular proliferations.
Shah RB; Kunju LP; Shen R; LeBlanc M; Zhou M; Rubin MA
Am J Clin Pathol; 2004 Oct; 122(4):517-23. PubMed ID: 15487448
[TBL] [Abstract][Full Text] [Related]
7. The utility of ERG/P63 double immunohistochemical staining in the diagnosis of limited cancer in prostate needle biopsies.
Yaskiv O; Zhang X; Simmerman K; Daly T; He H; Falzarano S; Chen L; Magi-Galluzzi C; Zhou M
Am J Surg Pathol; 2011 Jul; 35(7):1062-8. PubMed ID: 21623182
[TBL] [Abstract][Full Text] [Related]
8. Basal cell cocktail (34betaE12 + p63) improves the detection of prostate basal cells.
Zhou M; Shah R; Shen R; Rubin MA
Am J Surg Pathol; 2003 Mar; 27(3):365-71. PubMed ID: 12604893
[TBL] [Abstract][Full Text] [Related]
9. Alpha-methylacyl-CoA racemase: a variably sensitive immunohistochemical marker for the diagnosis of small prostate cancer foci on needle biopsy.
Magi-Galluzzi C; Luo J; Isaacs WB; Hicks JL; de Marzo AM; Epstein JI
Am J Surg Pathol; 2003 Aug; 27(8):1128-33. PubMed ID: 12883245
[TBL] [Abstract][Full Text] [Related]
10. Aberrant diffuse expression of p63 in adenocarcinoma of the prostate on needle biopsy and radical prostatectomy: report of 21 cases.
Osunkoya AO; Hansel DE; Sun X; Netto GJ; Epstein JI
Am J Surg Pathol; 2008 Mar; 32(3):461-7. PubMed ID: 18300803
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic utility of a p63/alpha-methyl-CoA-racemase (p504s) cocktail in atypical foci in the prostate.
Molinié V; Fromont G; Sibony M; Vieillefond A; Vassiliu V; Cochand-Priollet B; Hervé JM; Lebret T; Baglin AC
Mod Pathol; 2004 Oct; 17(10):1180-90. PubMed ID: 15205683
[TBL] [Abstract][Full Text] [Related]
12. ETS2 is a prostate basal cell marker and is highly expressed in prostate cancers aberrantly expressing p63.
Torres A; Alshalalfa M; Davicioni E; Gupta A; Yegnasubramanian S; Wheelan SJ; Epstein JI; De Marzo AM; Lotan TL
Prostate; 2018 Sep; 78(12):896-904. PubMed ID: 29761525
[TBL] [Abstract][Full Text] [Related]
13. Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas.
Edwards PC; Bhuiya T; Kelsch RD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 May; 97(5):613-9. PubMed ID: 15153875
[TBL] [Abstract][Full Text] [Related]
14. Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells.
De Marzo AM; Meeker AK; Epstein JI; Coffey DS
Am J Pathol; 1998 Sep; 153(3):911-9. PubMed ID: 9736039
[TBL] [Abstract][Full Text] [Related]
15. Glycoprotein A-80 in the human prostate: immunolocalization in prostatic intraepithelial neoplasia, carcinoma, radiation failure, and after neoadjuvant hormonal therapy.
Coogan CL; Bostwick DG; Bloom KJ; Gould VE
Urology; 2003 Jan; 61(1):248-52. PubMed ID: 12559317
[TBL] [Abstract][Full Text] [Related]
16. [Value of the antibody cocktail anti p63 + anti p504s for the diagnosis of prostatic cancer].
Molinié V; Hervé JM; Lebret T; Lugagne-Delpon PM; Saporta F; Yonneau L; Botto H; Baglin AC
Ann Pathol; 2004 Feb; 24(1):6-16. PubMed ID: 15192532
[TBL] [Abstract][Full Text] [Related]
17. Intermediate cells in human prostate epithelium are enriched in proliferative inflammatory atrophy.
van Leenders GJ; Gage WR; Hicks JL; van Balken B; Aalders TW; Schalken JA; De Marzo AM
Am J Pathol; 2003 May; 162(5):1529-37. PubMed ID: 12707036
[TBL] [Abstract][Full Text] [Related]
18. p63 is a prostate basal cell marker and is required for prostate development.
Signoretti S; Waltregny D; Dilks J; Isaac B; Lin D; Garraway L; Yang A; Montironi R; McKeon F; Loda M
Am J Pathol; 2000 Dec; 157(6):1769-75. PubMed ID: 11106548
[TBL] [Abstract][Full Text] [Related]
19. Prostatic basal cells in the peripheral and transitional zones: zonal variation in morphology and in immunophenotype.
Garcia FU; Haber MM; Chen X
Prostate; 2007 Nov; 67(15):1686-92. PubMed ID: 17879949
[TBL] [Abstract][Full Text] [Related]
20. Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders.
Glickman JN; Yang A; Shahsafaei A; McKeon F; Odze RD
Hum Pathol; 2001 Nov; 32(11):1157-65. PubMed ID: 11727253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
